SAN FRANCISCO--(BUSINESS WIRE)--In 2024, Unlearn ® achieved key milestones in advancing AI to eliminate trial and error in medicine. From securing $50M in Series C ...

Before I went through personal development, I was closed-minded. Negative. Jealous. Thought I knew better. I thought that successful people were just lucky. That I was born less privileged than the ...

Clinical trial tech company Unlearn scored $50 million in a Series B financing round led by Insight Partners. Other participants in the round include Radical Ventures, 8VC, DCVC, DCVC Bio and Mubadala ...

Patient-level digital twins expected to strengthen evidence generation in Phase1/2 clinical study evaluating VTx-002, a first-in-class vectorized antibody targeting TDP-43 pathology in patients with ...

Throughout the history of medicine, drug developers have tried to make clinical trials faster and more efficient. Artificial intelligence and machine-learning methods are some of the newer approaches ...

While it is true that experiences are an indispensable part of learning to start a venture, we must not forget that focusing an idea on innovation and not on established paradigms can be much more ...

One summer in college I canvassed for a local non-profit. We went door to door telling people about the organization and asking them to sign various petitions. I recited my spiel a hundred times. “Hi, ...

Reflecting on the importance and art of reskilling — learning and unlearning — comes at a timely moment. The Covid-19 pandemic has permitted us to learn how important soft skills are, and, more ...

While a lot of learning happens at Calvin University in any given week, the week of October 30—November 6, 2023, takes a different twist. Jane Bruin, director of the center for intercultural student ...